2-piperidone has been researched along with tacrolimus in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goto, R; Haga, S; Igarashi, R; Ozaki, M; Shibasaki, S; Todo, S; Tsunetoshi, Y; Umezawa, K; Wakayama, K; Yamashita, K; Zaitsu, M | 1 |
1 other study(ies) available for 2-piperidone and tacrolimus
Article | Year |
---|---|
Immunosuppressive effects of DTCM-G, a novel inhibitor of the mTOR downstream signaling pathway.
Topics: Animals; Benzamides; Calcineurin; Calcineurin Inhibitors; Cell Cycle; Cell Proliferation; Cells, Cultured; Combined Modality Therapy; Cyclohexanones; Dose-Response Relationship, Drug; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Interferon-gamma; Interleukin-2; Lymphocyte Activation; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; NF-kappa B; Phosphorylation; Piperidones; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; T-Lymphocytes; Tacrolimus; Time Factors; TOR Serine-Threonine Kinases | 2013 |